MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA – Get Free Report)’s stock price traded down 1.1% during trading on Wednesday . The company traded as low as $2.68 and last traded at $2.68. 38,203 shares were traded during mid-day trading, a decline of 88% from the average session volume of 311,536 shares. The stock had previously closed at $2.71.
MAIA Biotechnology Price Performance
The firm has a market capitalization of $64.08 million, a PE ratio of -1.70 and a beta of 0.33.
MAIA Biotechnology (NYSEAMERICAN:MAIA – Get Free Report) last released its quarterly earnings data on Friday, August 9th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.16. On average, analysts predict that MAIA Biotechnology, Inc. will post -1.25 EPS for the current year.
Hedge Funds Weigh In On MAIA Biotechnology
MAIA Biotechnology Company Profile
MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.
Featured Stories
- Five stocks we like better than MAIA Biotechnology
- How to Calculate Stock Profit
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- There Are Different Types of Stock To Invest In
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How is Compound Interest Calculated?
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for MAIA Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAIA Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.